CTLA‐4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15186
Abstract: Cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4), an inhibitory molecule on T‐cells, plays a key role in tumorigenesis and progression. In the present study, we investigated the effects of three polymorphisms in the CTLA‐4 gene on the risk… read more here.
Keywords: polymorphism contributes; ctla polymorphism; ovarian cancer; epithelial ovarian ... See more keywords